Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth in GNAS (Gα s ) mutant pancreas cancer
Science Advances · 2026
DOI: 10.1126/sciadv.aeh7186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Grant A Hagedorn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Mutation, GTP-Binding Protein alpha Subunits, Gs, Chromogranins. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Maintenance of fissed mitochondria is viewed as a defining feature of Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant cancers. However, regulation of this process by accompanying comutations or environmental factors is not clearly defined. Here, by analyzing a subset of pancreatic cancer lesions driven by concurrent Kras G12D and GNAS complex locus gene (GNAS R201C/H ) mutations, we found that despite the presence of mutant Kras, hyperactive Gnas R201C maintains mitochondria predominantly in a fused state, which is necessary for tumor growth. Multiplex proteomics, super-resolution microscopy, loss- and gain-of-function studies, coupled with metabolite rescue experiments, revealed that Gnas R201C -regulated branched-chain amino acid (BCAA) pathway is a previously unidentified regulator of mitochondrial morphology. Mechanistically, the BCAA pathway, the associated tricarboxylic acid cycle, and aspartate metabolism converge on nicotinamide adenine dinucleotide (NADH-NAD + ) metabolites to promote mitochondrial elongation. NAD + availability is crucial for mitochondrial fusion, as facilitating NAD + generation through alternative means promotes fusion. Collectively, we unraveled a new mechanism that drives mitochondrial fusion and showed that the combination of oncogenic signaling and metabolism can maintain distinct mitochondrial morphology within genetic subsets of KRAS-mutant pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.
- University of Cincinnati Cancer Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Department of Veterans Affairs, Veteran Affairs Medical Center, Cincinnati, OH, USA.
ORCID-Profile: Grant A Hagedorn, Jackson C Spieser, Noriko Hirai, Hanson Jiang, Wang Wang, Maria F Czyzyk-Krzeska, Krushna C Patra
Förderung
- BLRD VA
- NCI NIH HHS
- National Cancer Institute
- U.S. Department of Veterans Affairs
- Pancreatic Cancer Action Network
- UCCC Pilot Grants
Zitieren
APA
Hagedorn, G. A., Spieser, J. C., Hirai, N., Sato, Y., Valentine, J., Jiang, H., Wang, W., Czyzyk-Krzeska, M. F., & Patra, K. C. (2026). Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth in GNAS (Gα s ) mutant pancreas cancer. Science Advances. https://doi.org/10.1126/sciadv.aeh7186
Vancouver
Hagedorn GA, Spieser JC, Hirai N, Sato Y, Valentine J, Jiang H, et al. Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth in GNAS (Gα s ) mutant pancreas cancer. Science Advances. 2026. doi:10.1126/sciadv.aeh7186
BibTeX
@article{Hagedorn2026,
author = {Hagedorn, Grant A and Spieser, Jackson C and Hirai, Noriko and Sato, Yuki and Valentine, Jake and Jiang, Hanson and Wang, Wang and Czyzyk-Krzeska, Maria F and Patra, Krushna C},
title = {Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth in GNAS (Gα s ) mutant pancreas cancer},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeh7186}
}
EUVIMED